开盘暴涨225%!长风药业正式登陆港交所,吸入制剂龙头,国产替代叠加需求爆发

独角兽早知道
Oct 08

独角兽早知道 iponews|资讯撬动新资本|长风药业(02652.HK)今日成功在港交所主板上市,中信证券、招银国际为联席保荐人。长风药业主要专注于吸入技术及吸入药物的研发、生产及商业化,专注于治疗呼吸系统疾病,已开发出覆盖广泛患者、医学专科及治疗领域的产品组合。于往绩记录期间,长风药业自国家药品监督管理局(国家药监局)及美国食品药品监督管理局(FDA)获得六项产品批准并赚取大量销售收益,彰显...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10